# IVIG (Gamunex-C) Treatment Study for POTS Subjects

> **NCT03919773** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Postural Tachycardia Syndrome

## Interventions

- **DRUG:** IVIG
- **DRUG:** Albumin

## Key facts

- **NCT ID:** NCT03919773
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-29
- **Primary completion:** 2023-06-26
- **Final completion:** 2023-12-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919773, "IVIG (Gamunex-C) Treatment Study for POTS Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03919773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*